Recent advances in phospholipid nanoparticle-based drug delivery systems (SAB–PLC–NPs) have demonstrated the enhanced cellular uptake and anticancer efficacy of SAB in head and neck cancers (Li et al., 2016). The gene discussed is HSPG2; the disease is head and neck cancer.